These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30911946)

  • 1. False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.
    Nijhuis AAG; Dieng M; Khanna N; Lord SJ; Dalton J; Menzies AM; Turner RM; Allen J; Saw RPM; Nieweg OE; Thompson JF; Morton RL
    Ann Surg Oncol; 2019 Jun; 26(6):1860-1868. PubMed ID: 30911946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma.
    Turner RM; Dieng M; Khanna N; Nguyen M; Zeng J; Nijhuis AAG; Nieweg OE; Einstein AJ; Emmett L; Lord SJ; Menzies AM; Thompson JF; Saw RPM; Morton RL
    Ann Surg Oncol; 2021 Aug; 28(8):4561-4569. PubMed ID: 33393039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
    Abbott RA; Acland KM; Harries M; O'Doherty M
    Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma
    Koskivuo I; Kemppainen J; Giordano S; Seppänen M; Veräjänkorva E; Vihinen P; Minn H
    Acta Oncol; 2016 Nov; 55(11):1355-1359. PubMed ID: 27553064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study.
    Madu MF; Timmerman P; Wouters MWJM; van der Hiel B; van der Hage JA; van Akkooi ACJ
    Melanoma Res; 2017 Jun; 27(3):251-257. PubMed ID: 28225434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma.
    Ravichandran S; Nath N; Jones DC; Li G; Suresh V; Brys AK; Hanks BA; Beasley GM; Salama AKS; Howard BA; Mosca PJ
    Surg Oncol; 2020 Dec; 35():533-539. PubMed ID: 33161362
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Jaeger ZJ; Williams GA; Chen L; Mhlanga JC; Cornelius LA; Fields RC
    J Surg Oncol; 2022 Mar; 125(3):525-534. PubMed ID: 34741547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.
    Lewin J; Sayers L; Kee D; Walpole I; Sanelli A; Te Marvelde L; Herschtal A; Spillane J; Gyorki D; Speakman D; Estall V; Donahoe S; Pohl M; Pope K; Chua M; Sandhu S; McArthur GA; McCormack CJ; Henderson M; Hicks RJ; Shackleton M
    Ann Oncol; 2018 Jul; 29(7):1569-1574. PubMed ID: 29659679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients.
    Helvind NM; Aros Mardones CA; Hölmich LR; Hendel HW; Bidstrup PE; Sørensen JA; Chakera AH
    Eur J Surg Oncol; 2021 Dec; 47(12):3020-3027. PubMed ID: 34120809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.
    Stahlie EHA; van der Hiel B; Stokkel MPM; Schrage YM; van Houdt WJ; Wouters MW; van Akkooi ACJ
    J Surg Oncol; 2020 Dec; 122(7):1328-1336. PubMed ID: 32783266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Futility of imaging to stage melanoma patients with a positive sentinel lymph node.
    Holtkamp LHJ; Read RL; Emmett L; Thompson JF; Nieweg OE
    Melanoma Res; 2017 Oct; 27(5):457-462. PubMed ID: 28489677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma.
    Dieng M; Lord SJ; Turner RM; Nieweg OE; Menzies AM; Saw RPM; Einstein AJ; Emmett L; Thompson JF; Lo SN; Morton RL
    Ann Surg Oncol; 2022 May; 29(5):2871-2881. PubMed ID: 35142966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients.
    Young CJ; Zahid A; Choy I; Thompson JF; Saw RPM
    Eur J Surg Oncol; 2017 Nov; 43(11):2163-2169. PubMed ID: 28964611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental PET/CT findings in the cancer patient: how should they be managed?
    Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
    Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of computed tomography in the staging of patients with local-regional metastases of melanoma.
    Buzaid AC; Tinoco L; Ross MI; Legha SS; Benjamin RS
    J Clin Oncol; 1995 Aug; 13(8):2104-8. PubMed ID: 7636554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
    Leon-Ferre RA; Kottschade LA; Block MS; McWilliams RR; Dronca RS; Creagan ET; Allred JB; Lowe VJ; Markovic SN
    Melanoma Res; 2017 Aug; 27(4):335-341. PubMed ID: 28296712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional study.
    Riquelme-Mc Loughlin C; Podlipnik S; Bosch-Amate X; Riera-Monroig J; Barreiro A; Espinosa N; Moreno-Ramírez D; Giavedoni P; Vilana R; Sánchez M; Vidal-Sicart S; Carrera C; Malvehy J; Puig S
    J Am Acad Dermatol; 2019 Dec; 81(6):1330-1338. PubMed ID: 31163236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol.
    Dieng M; Khanna N; Nguyen MTH; Turner R; Lord SJ; Menzies AM; Allen J; Saw R; Nieweg OE; Thompson J; Morton RL
    BMJ Open; 2020 Nov; 10(11):e037857. PubMed ID: 33154047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.